Bal Pharma

{
  "main_header": {
    "sid": 555664,
    "name": "Bal Pharma",
    "stock_name": "Bal Pharma",
    "full_name": "Bal Pharma Ltd",
    "name_url": "stocks-analysis/bal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "69.57",
    "chg": 0.02,
    "chgp": "0.03%",
    "dir": 1,
    "prev_price": "69.55",
    "mcapval": "111.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524824,
    "symbol": "BALPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE083D01012",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "5.76 k",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bal-pharma-555664-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3828535",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BalPharmaLtd_mojoScore_3828535.png",
        "date": "2026-02-09 10:10:30",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 09 February 2026, providing investors with an up-to-date view of its performance and prospects."
      },
      {
        "title": "When is the next results date for Bal Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-bal-pharma-ltd-3821214",
        "imagepath": "",
        "date": "2026-02-04 23:17:00",
        "description": "The next results date for Bal Pharma Ltd is scheduled for 11 February 2026...."
      },
      {
        "title": "Bal Pharma Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3816450",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BalPharmaLtd_priceRelatedfactors_3816450.png",
        "date": "2026-02-02 11:19:53",
        "description": "Bal Pharma Ltd’s shares declined sharply to a fresh 52-week low of Rs.64 on 2 Feb 2026, marking a significant downturn in the stock’s performance over the past year. The stock’s fall reflects ongoing pressures on the company’s financial metrics and relative underperformance within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Bal Pharma Ltd Stock Falls to 52-Week Low of Rs.65.01",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-stock-falls-to-52-week-low-of-rs6501-3811513",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BalPharmaLtd_priceRelatedfactors_3811513.png",
        "date": "2026-01-30 12:06:05",
        "description": "Bal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.65.01 on 30 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed both its sector and the broader market, reflecting persistent pressures on its financial and operational metrics."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3809344",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BalPharmaLtd_mojoScore_3809344.png",
        "date": "2026-01-29 10:10:29",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 29 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Bal Pharma Ltd Falls to 52-Week Low of Rs.66 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-falls-to-52-week-low-of-rs66-amidst-continued-downtrend-3805640",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BalPharmaLtd_priceRelatedfactors_3805640.png",
        "date": "2026-01-27 10:10:52",
        "description": "Bal Pharma Ltd’s shares touched a fresh 52-week low of Rs.66 today, marking a significant decline amid sustained downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and valuation metrics."
      },
      {
        "title": "Bal Pharma Ltd Stock Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-stock-falls-to-52-week-low-amidst-continued-downtrend-3801681",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BalPharmaLtd_priceRelatedfactors_3801681.png",
        "date": "2026-01-23 11:30:38",
        "description": "Bal Pharma Ltd’s share price has declined to a fresh 52-week low of ₹67.15, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s shares are currently trading just 1.25% above this low, reflecting sustained pressure amid subdued financial performance and valuation concerns."
      },
      {
        "title": "Why is Bal Pharma Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bal-pharma-ltd-fallingrising-3797253",
        "imagepath": "",
        "date": "2026-01-21 01:04:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Despite opening the day with a 2% gain and touching an intraday high of ₹72.5, the stock ultimately succumbed to selling pressure, closing near its intraday low. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting stronger selling interest as the session progressed. The stock is now trading just 1.29% above its 52-week low of ₹67.15, underscoring its vulnerability.</p>\n<p>Bal Pharma’s performance today also lagged behind its sector peers, with the Pharmaceuticals &amp; Drugs sector declining by 2.1%. The stock underperformed the sector by 1.36%, signalling relative weakness amid broader industry challenges. Furthermore, the stock has been trading below all key moving a..."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3783128",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BalPharmaLtd_mojoScore_3783128.png",
        "date": "2026-01-06 10:10:26",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 122,
    "sid": "555664",
    "stock_news_url": "https://www.marketsmojo.com/news/bal-pharma-555664"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 31.12.2025.",
      "datetime": "03-Feb-2026",
      "details": "Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Unaudited standalone and consolidated financial results of the Company for the quarter ended 31.12.2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "12-Jan-2026",
      "details": "We are submitting newspaper advertisements of the postal ballot notice issued by the Company on 08.01.2026 and published on 09.01.2026.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Jan-2026",
      "details": "Confirmation as per Regulation 74(5) of SEBI(DP) Regulations for the quarter ended 31.12.2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "11 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bal Pharma Ltd has declared <strong>12%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bal Pharma Ltd is Rated Strong Sell

2026-02-09 10:10:30

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 09 February 2026, providing investors with an up-to-date view of its performance and prospects.

Read full news article

When is the next results date for Bal Pharma Ltd?

2026-02-04 23:17:00

The next results date for Bal Pharma Ltd is scheduled for 11 February 2026....

Read full news article

Bal Pharma Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-02-02 11:19:53

Bal Pharma Ltd’s shares declined sharply to a fresh 52-week low of Rs.64 on 2 Feb 2026, marking a significant downturn in the stock’s performance over the past year. The stock’s fall reflects ongoing pressures on the company’s financial metrics and relative underperformance within the Pharmaceuticals & Biotechnology sector.

Read full news article

Bal Pharma Ltd Stock Falls to 52-Week Low of Rs.65.01

2026-01-30 12:06:05

Bal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.65.01 on 30 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed both its sector and the broader market, reflecting persistent pressures on its financial and operational metrics.

Read full news article

Bal Pharma Ltd is Rated Strong Sell

2026-01-29 10:10:29

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 29 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Bal Pharma Ltd Falls to 52-Week Low of Rs.66 Amidst Continued Downtrend

2026-01-27 10:10:52

Bal Pharma Ltd’s shares touched a fresh 52-week low of Rs.66 today, marking a significant decline amid sustained downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and valuation metrics.

Read full news article

Bal Pharma Ltd Stock Falls to 52-Week Low Amidst Continued Downtrend

2026-01-23 11:30:38

Bal Pharma Ltd’s share price has declined to a fresh 52-week low of ₹67.15, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s shares are currently trading just 1.25% above this low, reflecting sustained pressure amid subdued financial performance and valuation concerns.

Read full news article

Why is Bal Pharma Ltd falling/rising?

2026-01-21 01:04:49

Recent Price Movement and Market Context

Despite opening the day with a 2% gain and touching an intraday high of ₹72.5, the stock ultimately succumbed to selling pressure, closing near its intraday low. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting stronger selling interest as the session progressed. The stock is now trading just 1.29% above its 52-week low of ₹67.15, underscoring its vulnerability.

Bal Pharma’s performance today also lagged behind its sector peers, with the Pharmaceuticals & Drugs sector declining by 2.1%. The stock underperformed the sector by 1.36%, signalling relative weakness amid broader industry challenges. Furthermore, the stock has been trading below all key moving a...

Read full news article

Bal Pharma Ltd is Rated Strong Sell

2026-01-06 10:10:26

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

View All News